. 2016 Mar 17;4(2):e00217. doi: 10.1002/prp2.217
© 2016 Merck Inc. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Figure 1.
Structure of [14C]‐cilengitide.